Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Drugs for treating infections caused by non-tubercular mycobacteria: A narrative review from the study group on mycobacteria of the Italian Society of Infectious …
Background Non-tuberculous mycobacteria (NTM) are generally free-living organism, widely
distributed in the environment, with sporadic potential to infect. In recent years, there has …
distributed in the environment, with sporadic potential to infect. In recent years, there has …
In vitro activity of omadacycline against clinical isolates of Nocardia
J Pham, RJ Benefield, N Baker… - Antimicrobial Agents …, 2024 - journals.asm.org
Nocardiosis typically requires a prolonged treatment duration of≥ 6 months and initial
combination therapy with 2–3 antibiotics. First-line regimens for nocardiosis are associated …
combination therapy with 2–3 antibiotics. First-line regimens for nocardiosis are associated …
Omadacycline drug susceptibility testing for non-tuberculous mycobacteria using oxyrase to overcome challenges with drug degradation
Background Drug susceptibility testing (DST) protocol of omadacycline against non-
tuberculous mycobacteria has not yet been established. We developed a method to …
tuberculous mycobacteria has not yet been established. We developed a method to …
Omadacycline pharmacokinetics/pharmacodynamics and efficacy against multidrug-resistant Mycobacterium tuberculosis in the hollow fiber system model
Seventy-five years ago, first-generation tetracyclines demonstrated limited efficacy in the
treatment of tuberculosis but were more toxic than efficacious. We performed a series of …
treatment of tuberculosis but were more toxic than efficacious. We performed a series of …
Sarecycline pharmacokinetics/pharmacodynamics in the hollow-fibre model of Mycobacterium avium complex: so near and yet so far
Background Poor sustained sputum culture conversion rates with the standard-of-care
therapy highlight the need for better drugs to treat Mycobacterium avium complex pulmonary …
therapy highlight the need for better drugs to treat Mycobacterium avium complex pulmonary …
An auxiliary strategy of partial least squares regression in pharmacokinetic/pharmacodynamic studies: A case of application of guhong injection in myocardial …
H Chen, C Li, C Shao, Y Wu, H Wan… - Journal of Food and …, 2023 - pmc.ncbi.nlm.nih.gov
Guhong injection (GHI) has been applied in the therapy of cardio-cerebrovascular disease
in clinic, but there is no report about the pharmacokinetic/pharmacodynamic (PK/PD) …
in clinic, but there is no report about the pharmacokinetic/pharmacodynamic (PK/PD) …
Isoniazid pharmacokinetics/pharmacodynamics as monotherapy and in combination regimen in the hollow fiber system model of Mycobacterium kansasii
Background There is limited high quality evidence to guide the optimal doses of drugs for
the treatment of Mycobacterium kansasii pulmonary disease (Mkn-PD). Methods We …
the treatment of Mycobacterium kansasii pulmonary disease (Mkn-PD). Methods We …
Minocycline intra-bacterial pharmacokinetic hysteresis as a basis for pharmacologic memory and a backbone for once-a-week pan-tuberculosis therapy
Background: There is need for shorter duration regimens for the treatment of tuberculosis,
that can treat patients regardless of multidrug resistance status (pan-tuberculosis). Methods …
that can treat patients regardless of multidrug resistance status (pan-tuberculosis). Methods …